AORT

Artivion, Inc. (NYSE:AORT) is a specialized medical device company founded in 1984 and headquartered in Kennesaw, Georgia. Originally known as CryoLife, Inc., the company rebranded to Artivion in January 2022 to better reflect its focus on aortic and cardiovascular innovations. The company has been publicly traded since 1993 and operates as a global manufacturer and distributor of medical devices and implantable human tissues, serving cardiac, vascular, thoracic, and general surgeons worldwide. Artivion has established itself as a key player in the cardiovascular surgery market through both organic growth and strategic acquisitions, with a particular emphasis on treating complex aortic diseases and heart valve replacements.